A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure

NCT03082508 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Dilated Cardiomyopathy
Heart Failure With Reduced Ejection Fraction

Interventions

DEVICE: Algisyl
DRUG: Standard Medical Therapy

Sponsor

LoneStar Heart, Inc.